Pharmacokinetic differences between rat tumour and lung tissues following isolated lung perfusion with cisplatin

European Journal of Cancer

Volumn 35, Issue 13, 1999, Pages 1846-1850

  Li, T S ^a   Kaneda, Y ^a   Saeki, K ^a   Ueda, K ^a   Zempo, N ^a   Esato, K ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cisplatin; Isolated lung perfusion; Lung; Pharmacokinetics; Tumour

Indexed keywords

CISPLATIN; PLATINUM;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; DRUG TISSUE LEVEL; HISTOLOGY; LUNG PERFUSION; LUNG TUMOR; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; CISPLATIN; LUNG; LUNG NEOPLASMS; MALE; RATS; RATS, INBRED F344;

EID: 0032712357     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(99)00226-9     Document Type: Article

References (26)

1. Pierpont H, Blades B. Lung perfusion with chemotherapeutic agents. J Thorac Cardiovasc Surg 1960, 39, 159-165.
2. Jacobs JK, Flexner JW, Scott HW Jr. Selective isolated perfusion of the right or left lung. J Thorac Cardiovasc Surg 1961, 42, 546-552.
3. Weksler B, Ng B, Lenert JT, Burt ME. Isolated single-lung perfusion with doxorubicin is pharmacokinetically superior to intravenous injection. Ann Thorac Surg 1993, 56, 209-214.
4. Weksler B, Schneider A, Ng B, Burt M. Isolated single lung perfusion in the rat: an experimental model. J Appl Physiol 1993, 74, 2736-2739.
5. Ratto GB, Esposito M, Leprini A, et al. In situ lung perfusion with cisplatin: an experimental study. Cancer 1993, 71, 2962-2970.
6. Ueda K, Sugi K, Li TS, Saeki K, Nawata S, Esato K. The longterm evaluation of pulmonary toxicity following isolated lung perfusion with melphalan in the rat. Anticancer Res 1999, 19, 141-147.
7. Weksler B, Lenert J, Ng B, Burt M. Isolated single lung perfusion with doxorubicin is effective in eradicating soft tissue sarcoma lung métastases in a rat model. J Thorac Cardiovasc Surg 1994, 107, 50-54.
8. Abolhoda A, Brooks A, Nawata S, Kaneda Y, Cheng H, Burt ME. Isolated lung perfusion with doxorubicin prolongs survival in a rodent model of pulmonary métastases. Ann Thorac Surg 1997,64, 181-184.
9. Ng B, Lenert JT, Weksler B, Port JL, Ellis JL, Burt ME. Isolated lung perfusion with FUDR is an effective treatment for colorectal adenocarcinoma lung métastases in rats. Ann Thorac Surg 1995, 59, 205-208.
10. Johnston MR, Minchen RF, Dawson CA. Lung perfusion with chemotherapy in patients with unresectable metastatic sarcoma to the lung or diffuse bronchioloalveolar carcinoma. J Thorac Cardiovasc Surg 1995, 110, 368-373.
11. Ratto GB, Toma S, Civalleri D, et al. Isolated lung perfusion with platinum in the treatment of pulmonary métastases from soft tissue sarcomas. J Thorac Cardiovasc Surg 1996, 112, 614-622.
12. Pass HI, Mew DJ, Kranda KG, Temeck BK, Donington JS, Rosenberg SA. Isolated lung perfusion with tumor necrosis factor for pulmonary métastases. Ann ThoracSurg 1996,61, 1609-1617.
13. Li TS, Sugi K, Ueda K, Nawata K, Nawata S, Esato K. Isolated lung perfusion with cisplatin in a rat lung solitary tumor nodule model. Anticancer Res 1998, 18, 4171-4176.
14. Nagashima A, Yasumoto K, Nakahashi H, Furukawa T, Inokuchi T, Nomoto K. Establishment and characterization of high and low-metastatic clones derived from a methylcholanthreneinduced rat fibrosarcoma. Cancer Res 1986, 46, 4420-4424.
15. Wang HY, Ross HM, Ng B, Burt ME. Establishment of an experimental intrapulmonary tumor nodule model. Ann Thorac Surg 1997, 64, 216-219.
16. Weksler B, Ng B, Lenert J, Burt M. A simplified method for endotracheal intubation in the rat. J Appl Physiol 1994, 76, 1823-1825.
17. Weksler B, Ng B, Lenert JT, Burt ME. Isolated single-lung perfusion: a study of the optimal perfusate and other pharmacokinetic factors. Ann Thorac Surg 1995, 60, 624-629.
18. Nawata S, Abecasis N, Ross HM, et al. Isolated lung perfusion with melphalan for the treatment of metastatic pulmonary sarcoma. J Thorac Cardiovasc Surg 1996, 112, 1542-1548.
19. Capewell S, Sudlow MF. Performance and prognosis in patient with lung cancer. The Edinburgh Lung Cancer Group. Thorax 1990,45,951-956.
20. Murray JF, Nadel JA. Textbook of Respiratory Medicine. Philadelphia, W.B. Saunders, 1998, 1267-1270.
21. Panettiere FJ, Vance RB, Stuckey WJ, Coltman CA Jr, Costanzi JJ, Chen TT. Evaluation of single-agent cisplatin in the management of non-small cell carcinoma of the lung: a Southwest Oncology Group Study. Cancer Treat Rep 1983, 86, 399-400.
22. Dirix LY, Oosterom AT. Diagnosis and treatment of soft tissue sarcomas in adults. Curr Opin Oncol 1994, 6, 372-383.
23. Milne EN, Noonan CD, Margulis AR, Stoughton JA. Vascular supply of pulmonary métastases. Experimental study in rats. Invest Radial 1969, 4, 215-229.
24. Milne EN, Margulis AR, Noonan CD, Stoughton JT. Histologie type-specific vascular patterns in rat tumors. Cancer 1967, 20, 1635-1646.
25. Milne EC. Circulation of primary and metastatic pulmonary neoplasms. A postmortem microarterigraphic study. Am J Roentogenol, Rad Therapy & Nuclear Med 1967, 100, 603-619.
26. Mcevoy GK, Litvak K, Welsh OH, et al. AHFS drug information. American Society of Hospital Pharmacists, INC, 7272, Wisconsin Avenue, Bethesda. 1993, 538-545.